S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells.

Laura MoscaMartina PaganoAnnalisa PecoraroLuigi BorzacchielloLuigi MeleGiovanna CacciapuotiMarina PorcelliGiulia RussoAnnapina Russo

Published in: International journal of molecular sciences (2020)

Results reported in this paper led us to propose S-adenosyl-l-methionine as a potential promising agent for cancer therapy by examining p53 and uL3 profiles in tumors to yield a better clinical outcomes.

Keyphrases

cancer therapy
herpes simplex virus
drug delivery
amino acid
human health
risk assessment
climate change